Your browser doesn't support javascript.
loading
Factors Affecting Citizen Trust and Public Engagement Relating to the Generation and Use of Real-World Evidence in Healthcare.
Horgan, Denis; Borisch, Bettina; Cattaneo, Ivana; Caulfield, Mark; Chiti, Arturo; Chomienne, Christine; Cole, Amanda; Facey, Karen; Hackshaw, Allan; Hendolin, Minna; Georges, Nadia; Kalra, Dipak; Tumiene, Birute; von Meyenn, Martina.
Afiliación
  • Horgan D; European Alliance for Personalised Medicine, 1040 Brussels, Belgium.
  • Borisch B; Department of Histopathology, University of Geneva, 1202 Geneva, Switzerland.
  • Cattaneo I; Novartis Farma SpA, 21040 Origgio, Italy.
  • Caulfield M; NIHR Barts Biomedical Research Centre, William Harvey Research Institute, Queen Mary University of London, London EC1M 6BQ, UK.
  • Chiti A; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20090 Milan, Italy.
  • Chomienne C; IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy.
  • Cole A; Cell Biology-Hematology Department, Université de Paris INSERM, 75010 Paris, France.
  • Facey K; Office of Health Economics, London SW1E 6QT, UK.
  • Hackshaw A; Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh EH8 9YL, UK.
  • Hendolin M; Faculty of Medical Sciences, University College London, London W1T 4TJ, UK.
  • Georges N; Sitra-The Finnish Innovation Fund, 00180 Helsinki, Finland.
  • Kalra D; Exact Sciences, 1201 Geneva, Switzerland.
  • Tumiene B; Faculty of Medicine and Health Sciences, University of Ghent, 9000 Ghent, Belgium.
  • von Meyenn M; Vilnius University Hospital Santariskiu Klinikos, 08661 Vilnius, Lithuania.
Article en En | MEDLINE | ID: mdl-35162696
ABSTRACT
The potential for the use of real-world data (RWD) to generate real-world evidence (RWE) that can inform clinical decision-making and health policy is increasingly recognized, albeit with hesitancy in some circles. If used appropriately, the rapidly expanding wealth of health data could improve healthcare research, delivery of care, and patient outcomes. However, this depends on two key factors (1) building structures that increase the confidence and willingness of European Union (EU) citizens to permit the collection and use of their data, and (2) development of EU health policy to support and shape data collection infrastructures, methodologies, transmission, and use. The great potential for use of RWE in healthcare improvement merits careful exploration of the drivers of, and challenges preventing, efficient RWD curation. Literature-based research was performed to identify relevant themes and discussion topics for two sets of expert panels, organized by the European Alliance for Personalised Medicine. These expert panels discussed steps that would enable a gradual but steady growth in the quantity, quality, and beneficial deployment of RWE. Participants were selected to provide insight based on their professional medical, economic, patient, industry, or governmental experience. Here, we propose a framework that addresses public trust and access to data, cross-border governance, alignment of evidence frameworks, and demonstrable improvements in healthcare decisions. We also discuss key case studies that support these recommendations, in accordance with the discussions at the expert panels.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Atención a la Salud / Confianza Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Int J Environ Res Public Health Año: 2022 Tipo del documento: Article País de afiliación: Bélgica

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Atención a la Salud / Confianza Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Int J Environ Res Public Health Año: 2022 Tipo del documento: Article País de afiliación: Bélgica